Corrigendum: Abd El Bary et al. Cost Effectiveness Analysis of Letrozole Compared with Tamoxifen as Initial Adjuvant Therapy for Postmenopausal Women with Endocrine Responsive Breast Cancer. Kasr El-Aini J Clin Oncol Nucl Med. 2009; 5(3-4): 11-17.
N. Bary, M. Maher, Mohamed M Elsherbini, M. Abdeen, T. Hashem
{"title":"Corrigendum: Abd El Bary et al. Cost Effectiveness Analysis of Letrozole Compared with Tamoxifen as Initial Adjuvant Therapy for Postmenopausal Women with Endocrine Responsive Breast Cancer. Kasr El-Aini J Clin Oncol Nucl Med. 2009; 5(3-4): 11-17.","authors":"N. Bary, M. Maher, Mohamed M Elsherbini, M. Abdeen, T. Hashem","doi":"10.21608/RESONCOL.2018.6131.1067","DOIUrl":null,"url":null,"abstract":"This corrigendum corrects the author list and affiliations of the article: Abd El Bary et al. Cost Effectiveness Analysis of Letrozole Compared with Tamoxifen as Initial Adjuvant Therapy for Postmenopausal Women with Endocrine Responsive Breast Cancer. Kasr El-Aini J Clin Oncol Nucl Med. 2009; 5(3-4): 11-17.In response to a request supported by documents from the corresponding author, the name Dr. Mohamed Elsherbini was added to the list of authors and the affiliation of Dr. Mohamed Abdeen was mentioned.The corrected version of this article replaces the primarily published one.","PeriodicalId":33915,"journal":{"name":"Research in Oncology","volume":"45 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/RESONCOL.2018.6131.1067","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This corrigendum corrects the author list and affiliations of the article: Abd El Bary et al. Cost Effectiveness Analysis of Letrozole Compared with Tamoxifen as Initial Adjuvant Therapy for Postmenopausal Women with Endocrine Responsive Breast Cancer. Kasr El-Aini J Clin Oncol Nucl Med. 2009; 5(3-4): 11-17.In response to a request supported by documents from the corresponding author, the name Dr. Mohamed Elsherbini was added to the list of authors and the affiliation of Dr. Mohamed Abdeen was mentioned.The corrected version of this article replaces the primarily published one.
更正：Abd-El-Bary等人。来曲唑与三苯氧胺作为内分泌反应性乳腺癌绝经后妇女的初始辅助治疗的成本效益分析。Kasr El Aini临床肿瘤学杂志，2009；5（3-4）：11-17。
本更正更正了这篇文章的作者名单和隶属关系：Abd El Bary等人。来曲唑与三苯氧胺作为内分泌反应性癌症绝经后妇女初始辅助治疗的成本效益分析。Kasr El Aini临床肿瘤学杂志，2009；5（3-4）：11-17根据通讯作者的文件支持的请求，Mohamed Elsherbini博士被添加到作者名单中，并提到Mohamed Abdeen博士的隶属关系。这篇文章的更正版本取代了最初发表的版本。
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
